BioAdaptives Inc. Diluted Shares Outstanding (Weighted Average)
BioAdaptives Inc. (BDPT) reported Diluted Shares Outstanding (Weighted Average) of 281.20 million shares for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-19.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding · last filed 2026-08-19
- BioAdaptives Inc. weighted average number of shares outstanding, diluted for the quarter ending 2026-06-30 was 281.20M shares, a 2849.60% increase year-over-year.
- BioAdaptives Inc. weighted average number of shares outstanding, diluted for the quarter ending 2026-03-31 was 12.01M shares, a 32.71% increase year-over-year.
- BioAdaptives Inc. weighted average number of shares outstanding, diluted for the quarter ending 2025-12-31 was 12.03M shares, a 21.39% increase year-over-year.
- BioAdaptives Inc. weighted average number of shares outstanding, diluted for the quarter ending 2025-09-30 was 10.24M shares, a 24.69% increase year-over-year.
- BioAdaptives Inc. weighted average number of shares outstanding, diluted for fiscal 2025 was 10.07M shares, a 22.61% increase from fiscal 2024.
- BioAdaptives Inc. weighted average number of shares outstanding, diluted for fiscal 2024 was 8.22M shares.
| Period end | Weighted Average Number of Shares Outstanding, Diluted 3 month | Weighted Average Number of Shares Outstanding, Diluted 6 month | Weighted Average Number of Shares Outstanding, Diluted 9 month | Weighted Average Number of Shares Outstanding, Diluted 12 month |
|---|---|---|---|---|
| 2026-06-30 | 281.20M shares 10-Q · filed 2026-08-19 | 280.11M shares 10-Q · filed 2026-08-19 | 101.75M shares derived: average of 3 quarters · filed 2026-08-19 | 78.87M shares derived: average of 4 quarters · filed 2026-08-19 |
| 2026-03-31 | 12.01M shares 10-Q · filed 2026-05-15 | 12.02M shares derived: average of 2 quarters · filed 2026-05-15 | 11.43M shares derived: average of 3 quarters · filed 2026-05-15 | 10.95M shares derived: average of 4 quarters · filed 2026-08-19 |
| 2025-12-31 | 12.03M shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-04-14 | 11.13M shares derived: average of 2 quarters · filed 2026-04-14 | 10.60M shares derived: average of 3 quarters · filed 2026-08-19 | 10.07M shares 10-K · filed 2026-04-14 |
| 2025-09-30 | 10.24M shares 10-Q · filed 2025-11-14 | 9.89M shares derived: average of 2 quarters · filed 2026-08-19 | 9.42M shares 10-Q · filed 2025-11-14 | 9.68M shares derived: average of 4 quarters · filed 2026-08-19 |
| 2025-06-30 | 9.53M shares 10-Q · filed 2026-08-19 | 9.00M shares 10-Q · filed 2026-08-19 | 9.50M shares derived: average of 3 quarters · filed 2026-08-19 | 9.18M shares derived: average of 4 quarters · filed 2026-08-19 |
| 2025-03-31 | 9.05M shares 10-Q · filed 2026-05-15 | 9.48M shares derived: average of 2 quarters · filed 2026-05-15 | 9.06M shares derived: average of 3 quarters · filed 2026-05-15 | 7.54M shares derived: average of 4 quarters · filed 2026-05-15 |
| 2024-12-31 | 9.91M shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-04-14 | 9.06M shares derived: average of 2 quarters · filed 2026-04-14 | 7.04M shares derived: average of 3 quarters · filed 2026-04-14 | 8.22M shares 10-K · filed 2026-04-14 |
| 2024-09-30 | 8.21M shares 10-Q · filed 2025-11-14 | 5.60M shares derived: average of 2 quarters · filed 2025-11-14 | 7.65M shares 10-Q · filed 2025-11-14 | |
| 2024-06-30 | 2.99M shares 10-Q · filed 2025-08-14 | 3.68M shares 10-Q · filed 2025-08-14 | ||
| 2024-03-31 | 7.70M shares 10-Q · filed 2025-05-13 | |||
| 2020-03-31 | 18.94M shares 10-Q/A · filed 2020-06-11 | |||
| 2019-03-31 | 22.62M shares 10-Q/A · filed 2020-06-11 |